B. Braun Medical Inc.Issues VoluntaryNationwideRecall of One (1) Lot ofCeftazidime for Injection USP and Dextrose Injection USP (50 mL), Duplex ContainerDueto Out-of-Specification Results for High Molecular Weight Polymers

Braun Medical Inc. (B. Braun) is voluntarily recalling one (1) lot of 2g Ceftazidime for Injection USP (2g) and Dextrose for Injection USP (50 ml) in Duplex® Container to the hospital/user level.. During stability testing of Batch H8J812, test results were found to exceed the specification limits fo

 
comments powered by Disqus